Reformulated Blood-Thinner Heparin Made By Baxter International, Inc. Less Potent, FDA Warns

MedPage Today -- WASHINGTON -- Beginning next week, heparin shipped to hospitals and pharmacies will be about 10% less potent than that currently available, a change that is likely to have clinical implications when the drug is administered as a bolus IV dose, the FDA said today.